drugset / Trial / NCT04134091
The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 2, randomized, double-blind, placebo controlled, three arm study in adult men with biopsy confirmed NASH. The study is aimed at evaluating efficacy and tolerability of LPCN 1144 in adult men with NASH.
Timeline
- Start
- 2019-08-27
- Primary completion
- 2021-06-24
- Completion
- 2021-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 238 mg | Oral |
| Subject | Testosterone Undecanoate | Small molecule | 225 mg | Oral |